Foghorn Therapeutics Inc.
NASDAQ:FHTX
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Price:
5.75
USD
-1.71%
Market Cap:
$325.2m
Balance Sheet
Balance Sheet Decomposition
Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc.
Balance Sheet Decomposition is not available for
Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc.
Balance Sheet
Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc.
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
40
|
15
|
93
|
101
|
52
|
80
|
55
|
|
| Cash Equivalents |
40
|
15
|
93
|
101
|
52
|
80
|
55
|
|
| Short-Term Investments |
0
|
0
|
93
|
53
|
294
|
154
|
188
|
|
| Total Receivables |
0
|
0
|
0
|
300
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
2
|
5
|
5
|
6
|
6
|
6
|
|
| Total Current Assets |
40
|
17
|
191
|
460
|
351
|
240
|
250
|
|
| PP&E Net |
2
|
4
|
62
|
56
|
49
|
43
|
33
|
|
| PP&E Gross |
2
|
4
|
62
|
56
|
49
|
43
|
33
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
5
|
9
|
12
|
15
|
|
| Other Long-Term Assets |
1
|
2
|
3
|
4
|
4
|
3
|
2
|
|
| Total Assets |
43
N/A
|
22
-48%
|
256
+1 046%
|
520
+103%
|
405
-22%
|
286
-29%
|
284
-1%
|
|
| Liabilities | ||||||||
| Accounts Payable |
2
|
3
|
4
|
4
|
5
|
6
|
4
|
|
| Accrued Liabilities |
1
|
5
|
13
|
16
|
17
|
17
|
18
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
4
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
2
|
29
|
33
|
35
|
46
|
|
| Total Current Liabilities |
4
|
13
|
19
|
49
|
55
|
58
|
67
|
|
| Long-Term Debt |
7
|
11
|
20
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
71
|
374
|
350
|
305
|
263
|
|
| Total Liabilities |
11
N/A
|
24
+114%
|
109
+360%
|
423
+287%
|
405
-4%
|
363
-10%
|
330
-9%
|
|
| Equity | ||||||||
| Common Stock |
71
|
87
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
43
|
94
|
163
|
264
|
373
|
472
|
558
|
|
| Additional Paid In Capital |
4
|
6
|
309
|
361
|
377
|
395
|
513
|
|
| Other Equity |
0
|
0
|
0
|
0
|
4
|
1
|
0
|
|
| Total Equity |
32
N/A
|
2
N/A
|
146
N/A
|
97
-34%
|
0
-100%
|
77
N/A
|
46
+41%
|
|
| Total Liabilities & Equity |
43
N/A
|
22
-48%
|
256
+1 046%
|
520
+103%
|
405
-22%
|
286
-29%
|
284
-1%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
11
|
11
|
37
|
41
|
42
|
42
|
56
|
|
Switch to:
Switch to:
See Also
Discover More
